_meta:
  version: '1.0'
  entity_type: node
  uuid: f24e9fe7-95d6-4ae6-aeb9-c14bfba14c43
  bundle: press_kit
  default_langcode: fr
  depends:
    f24d0f65-ae0a-4762-8ccb-a65e36d54b75: media
    1357d550-b00c-46dd-94ea-f2007b1bcb15: media
    94ff8e19-4c31-4322-b91f-7d6d457557a9: taxonomy_term
default:
  revision_uid:
    -
      target_id: 1
  revision_log:
    -
      value: 'edit content'
  status:
    -
      value: true
  uid:
    -
      target_id: 1
  title:
    -
      value: 'Press kit 9'
  created:
    -
      value: 1592931162
  promote:
    -
      value: false
  sticky:
    -
      value: false
  revision_translation_affected:
    -
      value: true
  metatag_normalized:
    -
      tag: meta
      attributes:
        name: title
        content: 'Press kit 9 | Vactory'
    -
      tag: link
      attributes:
        rel: canonical
        href: 'http://default/fr/press_kit/press-kit-9'
  path:
    -
      alias: /press_kit/press-kit-9
      langcode: fr
      pathauto: 1
  node_banner_disabled:
    -
      value: false
  node_summary:
    -
      value: 'Press kit 9'
  content_translation_source:
    -
      value: und
  content_translation_outdated:
    -
      value: false
  field_vactory_date:
    -
      value: '2020-07-01'
  field_vactory_excerpt:
    -
      value: 'he Hansa Biopharma group ("Share Rights Program 2020"), whereby not more than 36 individuals within the Hansa Biopharma group may participate. The participants will receive performance based share rights which, subject to certain conditions being met, give the right to receive ordinary shares in the Company. '
      format: plain_text
  field_vactory_media:
    -
      entity: f24d0f65-ae0a-4762-8ccb-a65e36d54b75
  field_vactory_media_file:
    -
      entity: 1357d550-b00c-46dd-94ea-f2007b1bcb15
  field_vactory_taxonomy_1:
    -
      entity: 94ff8e19-4c31-4322-b91f-7d6d457557a9
